News

MS Ireland launches new publications ‘Time to Act’ and ‘MS Treatment Decisions’

This week Declan Groeger shares his MS 'Fears'

Save the date

MS Ireland has made a detailed submission to the HSE Corporate Pharmaceutical Unit on Sativex. We would like to express our sincere gratitude to all the people with MS who completed our short survey on Sativex in January/February as the information collected from this has helped us to develop our submission. Download our submission   

Promising results from long term studies of stem cell transplants 

The MS Barometer is a comparative MS survey of the national situation in up to 34 European countries. See how Ireland compares to other countries in a variety of areas including access to treatments, employment and empowerment of people with Multiple Sclerosis.

This week Willeke Van Eeckhoutte shares her MS 'Hopes'

Save the Date! 

New centrally managed funding system established for Natalizumab (Tysabri) and Alemtuzumab (Lemtrada)

A new incidence study on MS in the Republic of Ireland has been published. The study, carried out by staff from St Vincent’s Hospital Dublin, was performed to ascertain all new cases of MS diagnosed from 1st March 2014 – 28th February 2015.